Field Trip Reveals Plans to Help Patients Access Psilocybin and MDMA Through Health Canada Jan 6, 2022
InMed’s Year-End Correspondence To Shareholders Focuses On Its Accomplishments And A Bullish Future Jan 6, 2022
Field Trip Announces Intention to Make Applications on Behalf of Patients to Health Canada’s Special Access Program… Jan 6, 2022
Revive Therapeutics To Expedite Patient Enrollments For Phase 3 COVID Oral Therapeutic Trial Jan 5, 2022
Health Canada’s Special Access Program Will Now Allow Doctors To Request Patient Access To Psychedelics Jan 5, 2022
